Kristen Sheppard | SVP, IR |
John Butler | CEO |
David Spellman | CFO |
Dr. Steven Burke | Chief Medical Officer |
Dell Faulkingham | Chief Commercial Officer |
Ally Bratzel | Piper Sandler |
Bert Hazlett | BTIG |
Eric Joseph | JP Morgan |
Ed Arce | H.C. Wainwright |
Good day, ladies and gentlemen, and welcome to Akebia Therapeutics Second Quarter of 2021 Financial Results and Business Update Conference Call.
As a reminder, this call is being recorded. I would now like to introduce your host for today’s event, Kristen Sheppard, Senior Vice President of Investor Relations with Akebia.
Thank you, and welcome to Akebia’s second quarter 2021 financial results and business update conference call. Please note that the press release detailing our results for the second quarter was issued earlier this morning and is available on the Investors section of our website.